Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market to reach USD 5.1 billion by 2025 | CAGR: 10.3%
Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market is valued at USD 2.1 billion in 2016 is anticipated to grow USD 5.1 billion with the compounded annual growth of 10.3% over the forecast period 2017-2025.
New York 29 May 2018, As per the new research study conducted by Bizwit Research & Consulting, Global NEUROSCIENCE ANTIBODIES, AND ASSAYS industry is poised to raise USD 5.1 billion by 2025. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size Estimates and Forecasts by Product (Reagent, Instruments), Technology (Immunoassay, Molecular Diagnostics), End-User (Research Institute, Hospital) and by Region (North America, Europe, Asia Pacific, and Rest of the World) 2017-2025.
The industry is seeming to be fairly competitive. Some of the leading market players include. Thermo Fisher Scientific, Abcam, Bio-Rad, Merck KGAA, Cell Signalling Technology,
Genscript, Rockland Immunochemicals. BioLegend, Santa Cruz Biotechnology, Tecan, F. Hoffmann-La Roche, Siemens. New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- The North America region estimated for dominating the NEUROSCIENCE ANTIBODIES AND ASSAYS market during the forecast period.
- North America will be the highest growing segment with respect to geographical segmentation by around XX%
- The pharmaceutical and biotechnology companies segment is expected to account for the largest share of the neuroscience antibodies and assays market.
- Asia PacificNEUROSCIENCE ANTIBODIES AND ASSAYS market is estimated to grow at the highest CAGR during the forecast period.
Bizwit Research & Consulting LLP has considered the following segments for the study:
- Molecular Diagnostics
By End User
- Research Institutes
- North America
- Asia Pacific
- Rest of the World